Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agiocur in Type 2 Diabetes Mellitus
NCT03552991Phase 4Completed
- Sponsor
- Samsung Medical Center
- Start
- Feb 2014
- Primary completion
- Oct 2015
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of ispaghula in type 2 diabetes mellitus (T2DM), sponsored by Samsung Medical Center. Started Feb 2014; status: completed.
02
Drugs
ispaghula
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03552991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03552991.